P-glycoprotein inhibitor (Nanjing EffecttPharm Drug Development Corporation)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameP-glycoprotein inhibitor (Nanjing EffecttPharm Drug Development Corporation)
Drug Alias Name1416
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP-glycoprotein 1 inhibitors
TargetsP-glycoprotein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesNanjing Yifang Pharmacy Research & Development Center Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNanjing Yifang Pharmacy Research & Development Center Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A